Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Naomi B. Haas, MD

Naomi B. Haas, MD Physician

Director, Prostate and Kidney Cancer Program Associate Professor of Pediatrics at the Children's Hospital of Philadelphia Associate Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Haas is employed by Penn Medicine.

About Dr. Naomi B. Haas

Recognized by America's Top Doctors, 2008, 2010 - 2018

Recognized by Best Doctors in America 2009 - 2012, 2015 - 2018

Recognized in Philadelphia magazine's 2010, 2018, and 2019 Top Docs issues

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Internal Medicine, 1988

Clinical Expertise:

  • Active Surveillance of Prostate Cancer
  • Adjuvant Chemotherapy
  • Adrenal Neoplasm
  • Angiomyolipoma
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Carcinoma In Situ of Prostate
  • Genitourinary Cancer Genomics
  • Immunotherapy
  • Malignancies of the Genitourinary System
  • Malignant Carcinoid Tumor of the Kidney
  • Malignant Tumor of Renal Pelvis
  • Metastatic Prostate Cancer
  • Neoadjuvant Chemotherapy
  • Prostate Cancer Genomics
  • Prostate Cancer Screening
  • Renal Cancer Genomics
  • Rhabdoid Tumor of the Kidney
  • Secondary Malignant Neoplasm of Kidney
  • Secondary Malignant Neoplasm of Urinary Organs
  • Transitional Cell Carcinoma
  • Urachal Cancer
  • Urethral Cancer
  • Von Hippel-Lindau Disease
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Northeastern Ohio University - College of Medicine
Residency: Abington Memorial Hospital
Fellowship: Fox Chase Cancer Center


American Association for Cancer Research, International American Society of Clinical Oncology, International Eastern Cooperative Oncology Group (Melanoma Committee, Genitourinary Committee), National ECOG/ACRIN, National NCI Genitourinary Steering Committee, National

Hospital Affiliation

Dr. Haas is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Selected Publications:

Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD: Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. Diabetes Care 37 (7): 1910-7,2014 .

Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A: Phase II trial of Vorinostat in advanced melanoma Invest New Drugs 32 (3): 526-34,2014.

Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL, Hussain M.: Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. J Clin Oncol 31 (4): 412-9,2013.

Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R.: Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma J Clin Oncol 31 (2): 181-6,2013.

Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.: Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. Int J Radiat Oncol Biol Phys 83 (5): 1493-9,2012.

Haas Naomi B, Lin Xinyi, Manola Judith, Pins Michael, Liu Glenn, McDermott David, Nanus David, Heath Elisabeth, Wilding George, Dutcher Janice: A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Medical oncology (Northwood, London, England) 29 (2): 761-7,2012.

Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N, Bekelman JE: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 83 (1): 8-15,2012.

Swisher-McClure Samuel, Pollack Craig E, Christodouleas John P, Guzzo Thomas J, Haas Naomi B, Vapiwala Neha, Bekelman Justin E: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. International journal of radiation oncology, biology, physics 83 (1): 8-15,2012.

Yeboa DN, Guzzo T, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K, Bekelman JE.: Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology : 2011.

Yeboa Debra Nana, Guzzo Thomas, Mitra Nandita, Christodouleas John P, Haas Naomi B, Vapiwala Neha, Armstrong Katrina, Bekelman Justin E: Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology 78 (5): 1107-13,2011.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor South Pavilion
Office #10-112
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 662-7402
Patient appointments: 800-789-7366

Related Links